Omega Healthcare Investors, Inc. (NYSE:OHI – Get Free Report) CEO C Taylor Pickett bought 20,000 shares of the company’s stock in a transaction on Wednesday, November 5th. The shares were bought at an average cost of $43.14 per share, for a total transaction of $862,800.00. Following the transaction, the chief executive officer owned 20,000 shares in the company, valued at $862,800. The trade was a ∞ increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link.
Omega Healthcare Investors Stock Performance
Shares of NYSE OHI traded down $0.43 during midday trading on Thursday, reaching $42.59. The company had a trading volume of 1,679,660 shares, compared to its average volume of 2,245,300. Omega Healthcare Investors, Inc. has a 1 year low of $35.04 and a 1 year high of $43.54. The business’s 50-day simple moving average is $41.50 and its 200 day simple moving average is $39.23. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The stock has a market cap of $12.56 billion, a P/E ratio of 26.29, a P/E/G ratio of 1.85 and a beta of 0.69.
Omega Healthcare Investors (NYSE:OHI – Get Free Report) last released its earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.02. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The firm had revenue of $260.74 million for the quarter, compared to the consensus estimate of $262.48 million. During the same period in the prior year, the firm earned $0.71 EPS. The firm’s revenue was up 14.4% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. On average, analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.
Omega Healthcare Investors Announces Dividend
Wall Street Analyst Weigh In
A number of research firms have issued reports on OHI. Wells Fargo & Company raised their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 21st. Cantor Fitzgerald initiated coverage on shares of Omega Healthcare Investors in a research note on Wednesday, October 1st. They issued an “overweight” rating and a $50.00 price objective on the stock. Royal Bank Of Canada raised their target price on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the stock a “sector perform” rating in a report on Thursday. Scotiabank upped their price target on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the company a “sector perform” rating in a report on Thursday, August 28th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of Omega Healthcare Investors in a research report on Wednesday, October 8th. Five analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Omega Healthcare Investors presently has an average rating of “Moderate Buy” and an average price target of $44.29.
Check Out Our Latest Analysis on OHI
Institutional Trading of Omega Healthcare Investors
A number of hedge funds have recently added to or reduced their stakes in OHI. Smartleaf Asset Management LLC increased its holdings in Omega Healthcare Investors by 40.9% in the second quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust’s stock valued at $34,000 after buying an additional 268 shares in the last quarter. Farther Finance Advisors LLC grew its position in shares of Omega Healthcare Investors by 7.1% during the 2nd quarter. Farther Finance Advisors LLC now owns 4,182 shares of the real estate investment trust’s stock valued at $153,000 after acquiring an additional 279 shares during the period. Guggenheim Capital LLC grew its position in shares of Omega Healthcare Investors by 1.0% during the 2nd quarter. Guggenheim Capital LLC now owns 29,398 shares of the real estate investment trust’s stock valued at $1,077,000 after acquiring an additional 280 shares during the period. United Services Automobile Association increased its stake in shares of Omega Healthcare Investors by 1.8% in the 1st quarter. United Services Automobile Association now owns 16,598 shares of the real estate investment trust’s stock valued at $632,000 after purchasing an additional 291 shares in the last quarter. Finally, UMB Bank n.a. increased its stake in shares of Omega Healthcare Investors by 11.0% in the 3rd quarter. UMB Bank n.a. now owns 2,965 shares of the real estate investment trust’s stock valued at $125,000 after purchasing an additional 293 shares in the last quarter. 65.25% of the stock is owned by hedge funds and other institutional investors.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Recommended Stories
- Five stocks we like better than Omega Healthcare Investors
- What is Put Option Volume?
- CAVA Stock Looking for Direction After Earnings Miss
- ETF Screener: Uses and Step-by-Step Guide
- 3 Small AI Stocks Ready to Explode (All Under $20)
- The Risks of Owning Bonds
- After 16% Fall, Analysts Eye a Big Recovery in Meta Platforms
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
